IPP is an intermediate in the classical β-Hydroxy β-methylglutaryl-CoA (HMG-CoA) reductase pathway (commonly called the mevalonate pathway) and in the non-mevalonate (methylerythritol 4-phosphate) MEP pathway of isoprenoid precursor biosynthesis. IPP toxicity presents a challenge in engineered microbial systems since its formation is unavoidable in terpene biosynthesis.
Learn more about What is isopentenyl pyrophosphate: https://gammadelta-t-therapy.c....reative-biolabs.com/
#health
Like
Comment
Share
